Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease

被引:90
作者
Barrachina, M.
Maes, T.
Buesa, C.
Ferrer, I.
机构
[1] Hosp Univ Bellvitge, Hosp Llobregat, IDIBELL, Inst Neuropatol,Serv Anat Patol, Barcelona 08907, Spain
[2] Univ Barcelona, Sch Pharm, Dept Biochem & Mol Biol, Cell Signalling Grp, E-08007 Barcelona, Spain
[3] Univ Barcelona, Hosp Llobregat, Dept Biol Cellular & Anat Patol, Unitat Neuropatol Expt, E-08007 Barcelona, Spain
关键词
Alzheimer's disease; beta A-amyloid; LAMP-1; lysosome; neurofibrillary tangle; tau;
D O I
10.1111/j.1365-2990.2006.00756.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lysosome-associated membrane protein 1 (LAMP-1) is a glycoprotein highly expressed in lysosomal membranes. The present study was initiated to test LAMP-1 mRNA and protein levels in post mortem frontal cortex (area 8) of Alzheimer's disease (AD) stages I-IIA/B and stages V-VIC of Braak and Braak, compared with age-matched controls. TaqMan PCR assays and Western blots demonstrated upregulation of LAMP-1 mRNA and protein in the cerebral cortex in ADVC. In addition, immunohistochemical studies have shown increased LAMP-1 immunoreactivity in neurones, and in glial cells surrounding senile plaques, in AD cases. Interestingly, LAMP-1 immunoreactivity has little correlation with phosphorylated tau deposition and neurofibrillary tangles (NFTs), as neurones with NFTs were rarely LAMP-1 immunoreactive. In contrast, LAMP-1 expression was enhanced in neurones with granulovacuolar degeneration. Finally, LAMP-1 occurred in microglia and multinucleated giant cells in one AD case in whom amyloid burden was cleared following beta A-peptide immunization. These findings support the participation of lysosomes in beta A-amyloid and, probably, in hyperphosphorylated tau turnover in AD.
引用
收藏
页码:505 / 516
页数:12
相关论文
共 20 条
[1]
Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease [J].
Bi, XN ;
Zhou, J ;
Lynch, G .
EXPERIMENTAL NEUROLOGY, 1999, 158 (02) :312-327
[2]
Novel cathepsin D inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus [J].
Bi, XN ;
Haque, TS ;
Zhou, J ;
Skillman, AG ;
Lin, B ;
Lee, CE ;
Kuntz, ID ;
Ellman, JA ;
Lynch, G .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1469-1477
[3]
Braak H, 1999, CEREB CORTEX, V14, P475, DOI DOI 10.1007/978-1-4615-4885-014
[4]
CARLSSON SR, 1988, J BIOL CHEM, V263, P18911
[5]
Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology [J].
Cataldo, AM ;
Peterhoff, CM ;
Schmidt, SD ;
Terio, NB ;
Duff, K ;
Beard, M ;
Mathews, PM ;
Nixon, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (08) :821-830
[6]
Cataldo AM, 1997, J NEUROSCI, V17, P6142
[7]
Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome [J].
Cataldo, AM ;
Barnett, JL ;
Mann, DMA ;
Nixon, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (06) :704-715
[8]
LYSOSOMAL HYDROLASES OF DIFFERENT CLASSES ARE ABNORMALLY DISTRIBUTED IN BRAINS OF PATIENTS WITH ALZHEIMER-DISEASE [J].
CATALDO, AM ;
PASKEVICH, PA ;
KOMINAMI, E ;
NIXON, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :10998-11002
[9]
GENE-EXPRESSION AND CELLULAR CONTENT OF CATHEPSIN-D IN ALZHEIMERS-DISEASE BRAIN - EVIDENCE FOR EARLY UP-REGULATION OF THE ENDOSOMAL LYSOSOMAL SYSTEM [J].
CATALDO, AM ;
BARNETT, JL ;
BERMAN, SA ;
LI, JH ;
QUARLESS, S ;
BURSZTAJN, S ;
LIPPA, C ;
NIXON, RA .
NEURON, 1995, 14 (03) :671-680
[10]
Duyckaerts C., 2003, NEURODEGENERATION MO, P47